Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
08049
Company Profile
Business description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is a pharmaceutical company. It is engaged in the manufacturing and distribution of Chinese medicines and pharmaceutical products. The company sells medicines under the brand names: Changlong and Qing Tong. The group has only one business segment which is the manufacture and distribution of Chinese medicines. It derives revenue from operations in the PRC.
Contact
625 & 639 Nathan Road
Room 1101-2, 11th Floor
Office Tower Two, Grand Plaza
Mong kok, Kowloon
Hong Kong
HKGSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,107
Stocks News & Analysis
stocks
Investors punish this ASX player after acquisition
We think the floundering stock price is not reflective of underlying asset value.
stocks
Revenue growth on track for undervalued ASX healthcare stock
Near-term cost growth does not change our long-term view.
stocks
Sales shine but broader macro outlook darkens for this ASX share
US stores are struggling, but our investment thesis hinges on the Australian rollout.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,137.30 | 15.50 | 0.17% |
| CAC 40 | 8,245.80 | 18.07 | -0.22% |
| DAX 40 | 23,806.99 | 273.64 | -1.14% |
| Dow JONES (US) | 48,185.80 | 275.88 | 0.58% |
| FTSE 100 | 10,603.48 | 5.40 | -0.05% |
| HKSE | 25,925.74 | 173.34 | 0.67% |
| NASDAQ | 22,822.42 | 187.42 | 0.83% |
| Nikkei 225 | 56,948.04 | 1,052.72 | 1.88% |
| NZX 50 Index | 13,163.94 | 109.87 | -0.83% |
| S&P 500 | 6,824.66 | 41.85 | 0.62% |
| S&P/ASX 200 | 8,945.20 | 20.80 | 0.23% |
| SSE Composite Index | 3,991.14 | 24.96 | 0.63% |